Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

V1RH21 Inhibitors

V1RH21 inhibitors are a class of chemical compounds designed to selectively interact with the V1RH21 protein, a component of the vacuolar-type H+-ATPase (V-ATPase) complex. This complex is integral to various cellular processes, primarily through its role in establishing and maintaining acidic environments within intracellular compartments such as lysosomes, endosomes, and vacuoles. The V1RH21 protein is part of the V1 domain of the V-ATPase, contributing to the ATP hydrolysis mechanism that drives proton transport across membranes. By influencing the function of this protein, V1RH21 inhibitors affect the activity of the entire V-ATPase complex.

The mechanism of action of V1RH21 inhibitors involves binding to the V1RH21 protein and disrupting its interaction with other subunits within the V1 domain. This binding interference impairs the assembly and stability of the V-ATPase complex, thereby affecting its ability to hydrolyze ATP effectively and pump protons. The inhibition of V1RH21 disrupts the acidification processes that are crucial for numerous cellular functions, including protein sorting, receptor-mediated endocytosis, and cellular homeostasis. Through this specific interaction, V1RH21 inhibitors provide valuable insights into the structural and functional dynamics of the V-ATPase complex, as well as the role of V1RH21 in proton transport and intracellular pH regulation.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, which may downregulate V1R197 expression by interfering with mTOR-mediated signaling pathways.

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$131.00
$651.00
7
(1)

Everolimus is an mTOR inhibitor that may downregulate V1R197 expression by interfering with mTOR-mediated signaling pathways.

Torin 1

1222998-36-8sc-396760
10 mg
$245.00
7
(1)

Torin 1 inhibits mTOR, which may downregulate V1R197 expression by interfering with mTOR-mediated signaling pathways.

AZD8055

1009298-09-2sc-364424
sc-364424A
10 mg
50 mg
$163.00
$352.00
12
(2)

AZD8055 is an mTOR inhibitor that may downregulate V1R197 expression by interfering with mTOR-mediated signaling pathways.

OSI-027

936890-98-1sc-364557
sc-364557A
10 mg
50 mg
$437.00
$1186.00
1
(0)

OSI-027 inhibits mTOR, which may downregulate V1R197 expression by interfering with mTOR-mediated signaling pathways.

KU 0063794

938440-64-3sc-361219
10 mg
$209.00
(1)

Ku-0063794 inhibits mTOR, which may downregulate V1R197 expression by interfering with mTOR-mediated signaling pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 inhibits PI3K, which may downregulate V1R197 expression by interfering with PI3K-mediated signaling pathways.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin inhibits PI3K, which may downregulate V1R197 expression by interfering with PI3K-mediated signaling pathways.

BEZ235

915019-65-7sc-364429
50 mg
$211.00
8
(1)

BEZ235 inhibits PI3K, which may downregulate V1R197 expression by interfering with PI3K-mediated signaling pathways.

GDC-0941

957054-30-7sc-364498
sc-364498A
5 mg
10 mg
$188.00
$199.00
2
(1)

GDC-0941 inhibits PI3K, which may downregulate V1R197 expression by interfering with PI3K-mediated signaling pathways.